A Study to evaluate the effectiveness of Homoeopathic Medicine Calcarea Carbonica 200C in managing Iron Deficiency Anaemia in Adolescent Girls

Efficacy of Calcarea Carbonica 200C in the homoeopathic management of mild to moderate iron deficiency anaemia among adolescent girls: A single blind randomized controlled trial. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101892

Enrollment

Registered

2026-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: HOMOEOPATHIC MEDICINE: Group 1 experimental group will be prescribed Calcarea Carbonica 200C 1 dose weekly and Group 2 experimental group will be prescribed Calcarea Carbonica 200C 1 do

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adolescent girls between the age group 10 to 16 years diagnosed with mild to moderate Iron deficiency anaemia having minimal indications of Calcarea Carbonica 2. Haemoglobin level from 8 g/dl to 11.99g/dl (mild to moderate Iron deficiency anaemia). 3. Cases in which parents will give assent for their child.

Exclusion criteria

Exclusion criteria: 1. Cases with recent history of malaria or dengue in last 3 months. 2. Cases with acute blood loss like bleeding per rectum or Meno-metrorrhagia etc. 3. Cases of adolescent pregnancies. 4. Cases with known case of any hemoglobinopathies like sickle cell anemia, thalassemia, etc. Or anemia of any chronic diseases.

Design outcomes

Primary

Measure	Time frame
To assess the efficacy of calcarea carbonica 200C in improving the symptoms and CBC parameters (Hb, Blood indices and peripheral smear for RBC morphology) in the homoeopathic management of mild to moderate iron deficiency anaemia among the adolescent girls as compared to control group receiving placebo.Timepoint: 0 months, 3 months, 6 months	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Chandrasekhar Goda

Dr M L Dhawale Memorial Homoeopathic Institute

sujchan18@gmail.com9322882918

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026